September 20, 2020
Patents Issued for the Medennium Phakic Refractive Lens – MPL, including: U.S. Patent 10,524,898; Korea Patent 10-2085521; China Patent ZL 2016800287136

March 13, 2012
Medennium receives Patent approval for the Aurium Photochromic IOL technology from the United States Patent Office. Patent US 8,133,274 with a patent term granted until Nov. 28, 2029.

Feb. 8, 2012
Medennium receives Patent approval for the Aurium Photochromic IOL from the European Patent Office. Patent 1758521

Nov. 10, 2010
Medennium receives Patent approval for the Aurium Photochromic IOL in China. Patent ZL200580016948.5 “Photochromic Intraocular Lenses and Methods of Making Same”

March 24, 2010
Medennium receives the SBIR Phase II grant # 2R44EOl7796-02A1 from the U.S. NIH National Eye Institute for development of the single-piece aspheric Model 404 photochromic intraocular lens, a design modification of the parent Model 400 photochromic intraocular lens developed under the Phase I grant.

Sept. 25, 2007
Medennium receives SBIR Phase I grant # 1R43EY017769-01A1 from the U.S. NIH National Eye Institute for development of the Aurium photochromic intraocular lens. This one year grant was used for product development, process development, and pre-clinical investigations for the Aurium Model 400 intraocular lens, the first photochromic intraocular lens. This grant led to the CE Mark registration and commercialization of this innovative lens design in over twenty countries outside the United States.

Sept. 17, 2004
Medennium receives a Small Business Innovation Research (SBIR) Phase I grant from the U.S. National Institutes of Health National Eye Institute, Grant No. 1R43EY015976-01, SmartIOL Accommodative Intraocular Lens. This one year grant was used for prototype development and pre-clinical evaluation of the SmartIOL full-size accommodating intraocular lens.